查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1800820

2025 年至 2033 年生物资讯市场报告（按产品和服务、应用、最终用途部门和地区划分）

Bioinformatics Market Report by Product and Service, Application, End-Use Sector, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球生物资讯市场规模达139亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到394亿美元，2025-2033年期间的复合年增长率（CAGR）为11.69%。科技的快速进步、基因组定序的不断增长、个人化医疗需求的激增、资料分析的成长、研发投入的不断增加、生物资料库的不断扩展以及对预防保健的日益关注，都是推动市场成长的一些因素。

生物资讯市场分析：

  • 市场成长与规模：生物资讯市场正经历大幅成长，这得益于其在医疗保健、农业和环境生物技术领域的关键作用。市场规模的不断扩大体现了这一扩张，预测显示其呈现强劲的上升趋势。这种成长的动力源于对整合资料解决方案日益增长的需求、生物资料量的激增以及生物资讯学在各个科学领域的广泛应用。正如生物资讯市场研究所强调的那样，该领域在解读复杂的生物数据集、推动个人化医疗创新以及增进我们对疾病遗传和分子基础的理解方面正变得不可或缺，从而为市场的扩张和发展做出了重大贡献。
  • 主要市场驱动因素：主要的市场驱动因素包括：由于成本效益高，对核酸和蛋白质定序的需求不断增长；云端运算的整合；以及微生物基因组计画的兴起。此外，对资料整合和管理的日益重视；临床诊断和精准医疗的广泛应用；生物製药行业的扩张；以及分子生物学的进步；对免疫基因组学的日益关注，这些因素正在推动市场成长。此外，对生物资讯学新创企业的投资增加；以及结合计算和生物学研究的合作项目的激增，共同推动了生物资讯学市场的成长，塑造了一个充满活力且快速发展的格局。
  • 技术进步：技术进步仍然是生物资讯市场的关键力量，持续创新是解决生物资料复杂性的关键。增强的运算能力、复杂的演算法和机器学习 (ML) 应用有助于推动基因组学和蛋白​​质组学分析的发展。这些技术进步不仅扩展了生物资讯学工具的功能，也拓宽了其在医疗保健、农业和环境研究等不同领域的适用性。这些进步确保了生物资讯学领域始终处于科学研究的前沿，促进了生物资料的快速、准确和经济高效的分析，这对于生物资讯市场趋势至关重要。
  • 产业应用：生物资讯学的产业应用涵盖医疗保健、製药、农业和环境科学领域。在医疗保健领域，它对于开发个人化医疗和了解遗传疾病至关重要。製药业依赖生物资讯学进行药物发现、开发和生物标记识别。在农业领域，它有助于作物改良和牲畜管理；而在环境科学领域，它用于生物多样性保护和生态系统健康监测。
  • 主要市场趋势：生物资讯市场的特点是人工智慧 (AI) 和机器学习 (ML) 在资料分析中的应用日益增多，个人化医疗对基因组资料解读的需求日益增长，在临床诊断中的应用日益广泛，以及基于云端的生物资讯解决方案的不断扩展。此外，对利用基因组资料的精准农业的重视、对生物标誌物发现需求的激增以及多组学资料整合用于综合分析的需求，正在推动市场成长。
  • 地理趋势：生物资讯市场呈现出显着的地理差异，北美凭藉其先进的技术基础设施、雄厚的研发投入以及关键产业参与者的强大影响力而处于领先地位。该地区的主导地位归功于其对新一代定序和高通量计算的快速应用，以及生物资讯学在医疗保健和农业生物技术领域的广泛应用。欧洲和亚太地区也是显着的贡献者，其中欧洲受益于其强大的研究框架，而亚太地区则由于生物技术企业的兴起和政府支持的不断增加而实现了快速增长。
  • 竞争格局：生物资讯市场的竞争格局瞬息万变，既有成熟企业，也有新兴新创企业。这些企业在创新、技术实力和策略合作方面展开竞争。市场领导者不断投资研发，推出先进的解决方案，以因应日益复杂的生物资料分析。随着企业努力提升产品服务并扩大市场覆盖范围，该产业也呈现併购趋势。
  • 挑战与机会：生物资讯市场充满挑战，包括资料复杂性、对专业技能的需求以及与资料隐私和安全相关的问题。然而，这些挑战也为市场成长和创新带来了独特的机会。生物资料量的不断增长催生了更复杂的生物资讯学工具的开发，这为人工智慧和机器学习的进步创造了机会。此外，个人化医疗需求的不断增长以及生物资讯学在各行各业的广泛应用，也为该行业带来了广阔的前景。

生物资讯市场趋势：

技术进步

技术进步是生物资讯市场发展的基石，深刻影响其发展和能力。计算演算法、高通量测序技术和增强型资料处理软体的创新彻底改变了生物资讯学，使海量生物数据集的分析速度和精度达到前所未有的水平。这些进步促进了复杂的基因组学和蛋白​​质组学分析，从而在理解生物过程和疾病机制方面取得了重大突破。它们也推动了更复杂的生物资讯学工具的开发，提高了基因组学、转录组学和其他各种组学领域的研究效率，从而加速了科学发现及其在个人化医疗、药物研发和其他领域的应用。

增加基因组定序

基因组定序的激增是关键驱动力，其推动力源自于定序技术成本的下降和可近性的提高。随着测序的日益普及，它会产生大量资料，因此需要先进的生物资讯工具来有效地储存、管理和分析资料。基因组资料的这种指数级增长对于推进个人化医疗、了解疾病的遗传易感性以及开发标靶疗法至关重要。快速且经济地进行基因组定序的能力已经彻底改变了生物学研究，使得人类遗传学、进化生物学和微生物基因组学的研究更加全面，从而突破了生物资讯学的界限，使其能够管理和解读这些海量数据集的复杂性。

个人化医疗需求激增

个人化医疗的需求正在显着塑造生物资讯学市场，强调医疗保健的个人化，即根据个别患者量身定制医疗决策和治疗方案。这种方法利用基因组和临床资料来了解疾病的分子基础，预测特定疾病的易感性，并设计个人化治疗方案。生物资讯学是这个过程不可或缺的一部分，它提供强大的计算能力来分析和解读影响健康和疾病的基因变异和分子模式。由此产生的洞察使医疗保健提供者能够做出更明智的决策，提供有针对性的治疗方案，并改善患者的治疗效果，从而推动了临床领域对复杂生物资讯解决方案的需求。

数据分析成长

生物资讯学中资料分析的发展具有变革性，它提供了强大的工具来解读基因组定序、基因表现研究和其他组学技术产生的复杂资料。生物资讯学越来越注重整合基因组学、转录组学、蛋白质组学和代谢组学等多个组学层面的资料，从而更全面地理解生物系统和疾病机制。此外，生物资讯学中的资料分析在很大程度上依赖机器学习 (ML) 和人工智慧 (AI) 技术进行预测建模、模式识别和资料解读。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球生物资讯市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品与服务

  • 知识管理工具
    • 主要类型
      • 通用知识管理工具
      • 专业的知识管理工具
  • 生物资讯平台
    • 主要类型
      • 手术模拟平台
      • 序列分析、比对和操作平台
      • 结构和功能分析平台
      • 其他的
  • 生物资讯服务
    • 主要类型
      • 数据分析服务
      • 资料库管理服务
      • 其他的

第七章：市场区隔：依应用

  • 基因组学
  • 化学资讯学与药物设计
  • 蛋白质体学
  • 转录组学
  • 代谢组学
  • 其他应用

第八章：市场区隔：依最终用途领域

  • 医学生物技术
  • 学者
  • 动物生物技术
  • 农业生物技术
  • 环境生物技术
  • 法医生物技术
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：SWOT分析

第 11 章：价值链分析

第 12 章：波特五力分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ABM Industries
    • Agilent Technologies
    • Biomax Informatics
    • Data4cure Inc.
    • Dnastar Inc.
    • Illumina Inc.
    • Life Technologies
    • Perkinelmer Inc.
    • Qiagen NV
    • Quest Diagnostics
    • Sophia Genetics SA
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
    • WuXi Nextcode Genomics
Product Code: SR112025A2129

The global bioinformatics market size reached USD 13.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.4 Billion by 2033, exhibiting a growth rate (CAGR) of 11.69% during 2025-2033. Rapid technological advancements, increasing genomic sequencing, surging demand for personalized medicine, data analytics growth, investment in research and development (R&D), expanding biological databases, and the rising focus on preventive care are some of the factors fostering the market growth.

Bioinformatics Market Analysis:

  • Market Growth and Size: The bioinformatics market is witnessing substantial growth, propelled by its critical role in healthcare, agriculture, and environmental biotechnology. The expansion is reflected in the increasing market size, with projections indicating robust upward trends. This growth is fueled by the escalating demand for integrated data solutions, the burgeoning volume of biological data, and the widespread application of bioinformatics in various scientific domains. As bioinformatics market research underscores, this sector is becoming indispensable in deciphering complex biological datasets, driving innovations in personalized medicine, and enhancing our understanding of genetic and molecular foundations of diseases, thereby contributing significantly to the market's expansion and evolution.
  • Major Market Drivers: The major market drivers include the escalating demand for nucleic acid and protein sequencing due to its cost-effectiveness, the integration of cloud computing, and the rise in microbial genome projects. Moreover, the increasing emphasis on data integration and management, widespread utilization in clinical diagnostics and precision medicine, expansion in the biopharmaceutical industry, and advancements in molecular biology, rising focus on immunogenomics, which is boosting the market growth. Apart from this, enhanced investment in bioinformatics startups and the surge in collaborative projects combining computational and biological research, collectively fuel the bioinformatics market growth, shaping a dynamic and rapidly evolving landscape.
  • Technological Advancements: Technological advancements remain a pivotal force in the bioinformatics market, where ongoing innovation is key to addressing the complexity of biological data. Enhanced computational power, sophisticated algorithms, and machine learning (ML) applications are instrumental in advancing genomic and proteomic analyses. These technological strides are not only expanding the capabilities of bioinformatics tools but also are broadening their applicability across different sectors, including healthcare, agriculture, and environmental studies. Such advancements ensure that the bioinformatics field stays at the forefront of scientific research, facilitating rapid, accurate, and cost-effective analysis of biological data, which is essential for bioinformatics market trends.
  • Industry Applications: The industry applications of bioinformatics span across healthcare, pharmaceuticals, agriculture, and environmental sciences. In healthcare, it's pivotal for developing personalized medicine and understanding genetic disorders. The pharmaceutical sector relies on bioinformatics for drug discovery, development, and biomarker identification. In agriculture, it aids in crop improvement and livestock management, while in environmental science, it's used for biodiversity conservation and monitoring ecosystem health.
  • Key Market Trends: The bioinformatics market is characterized by the increasing use of artificial intelligence (AI) and ML in data analysis, the rise of personalized medicine requiring genomic data interpretation, the growing application in clinical diagnostics, and the expansion of cloud-based bioinformatics solutions. Moreover, the emphasis on precision agriculture leveraging genomic data, the surge in demand for biomarker discovery, and the integration of multi-omics data for comprehensive analysis are boosting the market growth.
  • Geographical Trends: The bioinformatics market exhibits significant geographical disparities, with North America leading due to its advanced technological infrastructure, substantial investments in R&D, and strong presence of key industry players. The region's dominance is attributed to its rapid adoption of next-generation sequencing, high-throughput computing, and extensive use of bioinformatics in healthcare and agricultural biotechnology. Europe and Asia-Pacific are also notable contributors, with Europe benefiting from its robust research framework and Asia-Pacific witnessing fast-paced growth due to rising biotechnology ventures and increasing governmental support.
  • Competitive Landscape: The competitive landscape of the bioinformatics market is intensely dynamic, featuring a mix of established companies and emerging startups. These entities compete on innovation, technological prowess, and strategic collaborations. Market leaders are continuously investing in R&D to introduce advanced solutions that cater to the growing complexity of biological data analysis. The sector is also witnessing a trend of mergers and acquisitions, as companies strive to enhance their offerings and expand their market reach.
  • Challenges and Opportunities: The bioinformatics market is laden with challenges, including data complexity, the need for specialized skills, and issues related to data privacy and security. However, these challenges present unique opportunities for market growth and innovation. The increasing volume of biological data necessitates the development of more sophisticated bioinformatics tools, creating opportunities for advancements in AI and machine learning. Moreover, the growing demand for personalized medicine and the expanding application of bioinformatics across various industries offer vast prospects for the sector.

Bioinformatics Market Trends:

Technological advancements

Technological advancements are a cornerstone driver of the bioinformatics market, profoundly impacting its growth and capabilities. Innovations in computational algorithms, high-throughput sequencing technologies, and enhanced data processing software have revolutionized bioinformatics, enabling the analysis of vast biological datasets at unprecedented speeds and accuracy. These advancements facilitate complex genomic and proteomic analyses, leading to significant breakthroughs in understanding biological processes and disease mechanisms. They also enable the development of more sophisticated bioinformatics tools, improving the efficiency of research in genomics, transcriptomics, and various other omics fields, thereby accelerating scientific discoveries and their applications in personalized medicine, drug discovery, and other areas.

Increased genomic sequencing

The surge in genomic sequencing is a pivotal driver, fueled by the declining costs and improved accessibility of sequencing technologies. As sequencing becomes more widespread, it generates enormous volumes of data, necessitating advanced bioinformatics tools for effective data storage, management, and analysis. This exponential increase in genomic data is crucial for advancing personalized medicine, understanding genetic predispositions to diseases, and developing targeted therapies. The ability to sequence genomes rapidly and affordably has transformed biological research, enabling more comprehensive studies of human genetics, evolutionary biology, and microbial genomics, thus pushing the boundaries of bioinformatics to manage and decipher the complexity of these vast datasets.

Surging demand for personalized medicine

The demand for personalized medicine is significantly shaping the bioinformatics market, emphasizing the customization of healthcare, with medical decisions and treatments tailored to individual patients. This approach leverages genomic and clinical data to understand the molecular basis of diseases, predict the susceptibility to specific illnesses, and design personalized treatment regimens. Bioinformatics is integral to this process, providing the computational power to analyze and interpret the genetic variations and molecular patterns that influence health and disease. The resulting insights enable healthcare providers to make more informed decisions, offer targeted therapies, and improve patient outcomes, thereby driving the demand for sophisticated bioinformatics solutions in clinical settings.

Data analytics growth

The growth of data analytics in bioinformatics is transformative, offering powerful tools to decipher the complex data generated by genomic sequencing, gene expression studies, and other omic technologies. Bioinformatics is increasingly focusing on integrating data from multiple omics levels such as genomics, transcriptomics, proteomics, and metabolomics that provides a more comprehensive understanding of biological systems and disease mechanisms. Moreover, data analytics in bioinformatics heavily relies on machine learning (ML) and artificial intelligence (AI) techniques for predictive modeling, pattern recognition, and data interpretation.

Bioinformatics Industry Segmentation:

Breakup by Product and Service:

  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Platforms
    • Surgical Simulation Platforms
    • Sequence Analysis, Alignment and Manipulation Platforms
    • Structural and Functional Analysis Platforms
    • Others
  • Bioinformatics Services
    • Data Analysis Services
    • Database Management Services
    • Others

Bioinformatics platforms dominates the market

The bioinformatics platforms segment is driven by the increasing complexity and volume of biological data, necessitating advanced platforms for data analysis, integration, and interpretation. The surge in genomic and proteomic studies, the expanding applications of next-generation sequencing, and the growing demand for integrative platforms for multidisciplinary research are key factors. These platforms are essential for translating vast biological data sets into comprehensible insights, facilitating advancements in personalized medicine, drug discovery, and genetic research.

The knowledge management tools segment is driven by the increasing need for organizations to harness the vast amounts of data generated and to transform this data into actionable insights. Factors such as the growing emphasis on decision-making based on data-driven insights, the escalating need for market intelligence, and the rising importance of enhancing operational efficiency are pivotal. Organizations are adopting these tools to improve innovation, streamline operations, and maintain competitive advantages by effectively managing, retrieving, and utilizing knowledge.

The bioinformatics services segment is driven by the increasing outsourcing of bioinformatics projects, the need for specialized expertise, and the growing demand for cost-effective and efficient data analysis solutions. Pharmaceutical and biotechnology companies, along with academic and research institutions, are leveraging these services to cope with the complexity of bioinformatics analyses, focus on core competencies, and accelerate the pace of research and development. The services segment is crucial for providing tailored solutions that address specific research requirements, ensuring high-quality analysis and interpretation of biological data.

Breakup by Application:

  • Genomics
  • Chemoinformatics and Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Genomics accounts for the majority of the market share

The genomics segment is driven by the increasing affordability of sequencing technologies, advancements in high-throughput sequencing methods, and a growing emphasis on personalized medicine. The expanding applications of genomics in understanding genetic variations, disease mechanisms, and therapeutic targets are catalyzing its adoption across various fields, including healthcare, agriculture, and biotechnology. This segment benefits significantly from continuous innovations in sequencing technologies, bioinformatics tools, and the integration of genomics with other omics disciplines, enhancing its impact on precision medicine, genetic research, and evolutionary biology.

The chemoinformatics and drug design segment is driven by the increasing demand for new therapeutic agents, the need for cost-effective drug development processes, and the integration of artificial intelligence and machine learning technologies. This segment leverages computational tools to understand drug-receptor interactions, predict pharmacokinetic and toxicological properties, and streamline the drug discovery pipeline. The growth of this segment is further propelled by the pharmaceutical industry's shift towards data-driven methodologies, the expansion of chemical databases, and the advancement of simulation and modeling techniques, all of which enhance the efficiency and effectiveness of drug discovery and development.

The proteomics segment is driven by the increasing advancements in mass spectrometry technologies, the growing demand for personalized medicine, and the expanding applications of proteomics in biomarker discovery and disease diagnostics. This segment benefits from the integration of proteomics data with other omics data, which enhances the understanding of cellular processes and disease mechanisms. The continuous improvement in proteomic workflows, the development of high-throughput and sensitive analytical techniques, and the increasing focus on systems biology are key factors contributing to the growth of this segment, enabling deeper insights into protein function, structure, and interactions.

The transcriptomics segment is driven by the increasing adoption of RNA sequencing technologies, the growing interest in understanding gene expression patterns, and the expanding application of transcriptomics in disease research and drug discovery. This segment is benefiting from advancements in sequencing technologies, computational biology, and the integration of transcriptomic data with genomics and proteomics, which enriches the understanding of gene regulation, cellular responses, and molecular mechanisms underlying various conditions.

The metabolomics segment is driven by the increasing application of metabolomics in clinical diagnostics, the growing emphasis on understanding metabolic pathways, and the advancements in analytical techniques like mass spectrometry. This segment is crucial for elucidating the functional state of biological systems, providing insights into the phenotypic changes caused by genetic or environmental factors. The integration of metabolomics with other omics technologies, the growing demand for biomarker discovery, and the expanding applications in personalized medicine and nutritional research are key factors propelling the growth of this segment, offering comprehensive insights into the metabolic processes and their implications in health and disease.

The others segment in bioinformatics is driven by the increasing demand for integrated omics approaches, the expansion of applications in areas such as epigenomics, pharmacogenomics, and environmental genomics, and the growing need for advanced computational tools to analyze complex datasets. This segment encompasses a variety of specialized fields that leverage bioinformatics technologies to explore the biological data beyond conventional omics studies.

Breakup by End-Use Sector:

  • Medical Biotechnology
  • Academics
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Others

Medical biotechnology accounts for the majority of the market share

The medical biotechnology segment is driven by the increasing demand for personalized medicine, advancements in genetic engineering, and the growing prevalence of chronic diseases. Innovations in gene therapy, stem cell technology, and regenerative medicine are revolutionizing treatments, making them more effective and tailored to individual genetic profiles. The surge in biopharmaceuticals, including vaccines and therapeutic proteins, and the emphasis on early disease detection and prevention are key factors propelling this segment forward. These developments are enhancing patient outcomes, reducing healthcare costs, and leading to the discovery of novel therapeutics, thereby fueling the growth of medical biotechnology.

The academics segment is driven by the increasing collaboration between research institutions and the biotechnology industry, the growing focus on genomic and proteomic research, and the rising demand for biotechnology education. Enhanced funding for research projects, the integration of advanced technologies in academic curricula, and the emphasis on developing innovative biotechnological applications are pivotal.

The animal biotechnology segment is driven by the increasing investment in veterinary research, the demand for enhanced animal health and productivity, and the development of genetically modified animals. Breakthroughs in animal genetics, vaccine development, and reproductive technologies are instrumental in improving animal breeding, disease resistance, and protein production. This segment's growth is further supported by the ethical production of transgenic animals, advancements in cloning and stem cell research, and the application of biotechnological methods in wildlife conservation, thus offering significant contributions to veterinary medicine and livestock management.

The agricultural biotechnology segment is driven by the increasing global demand for food, the need for pest and disease resistance, and the urgency to adapt to climate change. Genetic modifications in crops for improved yield, quality, and nutritional value, along with advancements in biopesticides and biofertilizers, are crucial developments. This segment leverages biotechnological tools for sustainable farming practices, enhancing crop resilience to environmental stresses, and reducing agricultural inputs, which are vital for food security and agricultural sustainability, thus playing a key role in the global agricultural landscape.

The environmental biotechnology segment is driven by the increasing need for waste management, pollution reduction, and sustainable environmental practices. The application of microbial systems for bioremediation, the development of bioenergy sources, and the use of biotechnological processes for water treatment are pivotal. This segment focuses on harnessing biological systems for the detoxification of contaminated environments, the recycling of waste materials, and the production of green energy, thereby contributing significantly to environmental sustainability and the conservation of natural resources.

The forensic biotechnology segment is driven by the increasing demand for accurate and speedy forensic investigations and advancements in molecular diagnostics. The application of biotechnological tools in crime scene analysis, the development of sophisticated forensic databases, and the enhancement of legal frameworks are key factors. This segment benefits from the precision and reliability of biotechnological methods in forensic science, providing crucial evidence in criminal cases, identifying victims of disasters, and contributing to the justice system, thereby playing a vital role in law enforcement and forensic investigations.

The others segment, which includes industrial, marine, and food biotechnology, is driven by the diverse applications of biotechnological processes in various sectors. The development of bio-based chemicals, the use of enzymes in industrial processes, and the advancement of marine biotechnology for new drug discovery are key factors.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest Bioinformatics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others);Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America bioinformatics market is driven by the increasing investment in biotechnology and pharmaceutical research, the presence of a robust technological infrastructure, and significant governmental and private funding for genomics research. The region benefits from a well-established healthcare system, a high rate of adoption of advanced technologies, and the presence of leading bioinformatics companies, which collectively fuel innovation and market expansion.

The Europe bioinformatics market is driven by the increasing focus on precision medicine, strong governmental support for research in genomics, and collaborations between academia and the biotech industry. The region's advanced healthcare infrastructure, coupled with high healthcare expenditure, facilitates the adoption of bioinformatics tools, supporting the market's growth and the development of new applications.

The Asia Pacific bioinformatics market is driven by the rapidly growing biotechnology sector, increasing government initiatives in genomics research, and rising investments in healthcare technology. The region's growing emphasis on personalized medicine and the expansion of the pharmaceutical and agriculture sectors contribute significantly to the adoption of bioinformatics, making it a fast-evolving market.

The Latin America bioinformatics market is driven by the increasing healthcare expenditure, growing biotech and pharmaceutical sectors, and rising awareness about the potential of genomics research. Although in the nascent stage, the market benefits from the gradual adoption of advanced technologies and the improving healthcare infrastructure, which are pivotal for the region's bioinformatics advancements.

The Middle East and Africa bioinformatics market is driven by the growing demand for personalized healthcare, increasing investment in healthcare infrastructure, and the rising prevalence of genetic disorders. The market is also benefiting from the expanding research in genomics and the increasing collaboration between regional and international research institutions, fostering a gradual yet promising growth in the bioinformatics landscape.

Leading Key Players in the Bioinformatics Industry:

In the bioinformatics market, key players are actively engaged in a range of strategic activities to bolster their market position and respond to the rapidly evolving technological landscape. They are heavily investing in research and development (R&D) to innovate and enhance bioinformatics tools, software, and services, ensuring they can handle the increasing complexity and volume of biological data. Collaborations and partnerships are a cornerstone strategy, as companies join forces with academic institutions, research labs, and other firms to combine expertise, share resources, and co-develop advanced solutions that cater to the specific needs of the scientific community. Additionally, these players are focusing on expanding their product portfolios through mergers and acquisitions, enabling them to offer more comprehensive solutions and gain a competitive edge. They are also intensifying their efforts in customer training and support, ensuring users can maximize the benefits of their bioinformatics solutions, thereby driving market growth and innovation.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • ABM Industries
  • Agilent Technologies
  • Biomax Informatics
  • Data4Cure Inc.
  • Dnastar Inc.
  • Illumina Inc.
  • Life Technologies
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • Sophia Genetics SA
  • Thermo Fisher Scientific Inc.
  • Waters Corp
  • WuXi Nextcode Genomics

Key Questions Answered in This Report

  • 1.What is the global bioinformatics market growth?
  • 2.What are the global bioinformatics market drivers?
  • 3.What are the key industry trends in the global bioinformatics market?
  • 4.What is the impact of COVID-19 on the global bioinformatics market?
  • 5.What is the global bioinformatics market breakup by product and service?
  • 6.What are the major regions in the global bioinformatics market?
  • 7.Who are the key companies/players in the global bioinformatics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioinformatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Knowledge Management Tools
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Generalized Knowledge Management Tools
      • 6.1.2.2 Specialized Knowledge Management Tools
    • 6.1.3 Market Forecast
  • 6.2 Bioinformatics Platforms
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Surgical Simulation Platforms
      • 6.2.2.2 Sequence Analysis, Alignment and Manipulation Platforms
      • 6.2.2.3 Structural and Functional Analysis Platforms
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast
  • 6.3 Bioinformatics Services
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Data Analysis Services
      • 6.3.2.2 Database Management Services
      • 6.3.2.3 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemoinformatics and Drug Design
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Proteomics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Transcriptomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Metabolomics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Other Applications
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-Use Sector

  • 8.1 Medical Biotechnology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Animal Biotechnology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Agricultural Biotechnology
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Environmental Biotechnology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Forensic Biotechnology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 ABM Industries
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Agilent Technologies
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Biomax Informatics
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Data4cure Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Dnastar Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Life Technologies
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Qiagen N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Quest Diagnostics
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sophia Genetics SA
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis
    • 13.3.14 WuXi Nextcode Genomics
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Bioinformatics Market: Major Drivers and Challenges
  • Figure 2: Global: Bioinformatics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Bioinformatics Market: Breakup by Product and Service (in %), 2024
  • Figure 4: Global: Bioinformatics Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Bioinformatics Market: Breakup by End-Use Sector (in %), 2024
  • Figure 6: Global: Bioinformatics Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Bioinformatics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Bioinformatics (Knowledge Management Tools) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Bioinformatics (Knowledge Management Tools) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Bioinformatics (Bioinformatics Platforms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Bioinformatics (Bioinformatics Platforms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Bioinformatics (Bioinformatics Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Bioinformatics (Bioinformatics Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Bioinformatics (Genomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Bioinformatics (Genomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Bioinformatics (Chemoinformatics and Drug Design) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Bioinformatics (Chemoinformatics and Drug Design) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Bioinformatics (Proteomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Bioinformatics (Proteomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Bioinformatics (Transcriptomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Bioinformatics (Transcriptomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Bioinformatics (Metabolomics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Bioinformatics (Metabolomics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Bioinformatics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Bioinformatics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Bioinformatics (Medical Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Bioinformatics (Medical Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Bioinformatics (Academics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Bioinformatics (Academics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Bioinformatics (Animal Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Bioinformatics (Animal Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Bioinformatics (Agricultural Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Bioinformatics (Agricultural Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Bioinformatics (Environmental Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Bioinformatics (Environmental Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Bioinformatics (Forensic Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Bioinformatics (Forensic Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Bioinformatics (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Bioinformatics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia Pacific: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia Pacific: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Bioinformatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Bioinformatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Global: Bioinformatics Industry: SWOT Analysis
  • Figure 89: Global: Bioinformatics Industry: Value Chain Analysis
  • Figure 90: Global: Bioinformatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioinformatics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Bioinformatics Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
  • Table 3: Global: Bioinformatics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Bioinformatics Market Forecast: Breakup by End-Use Sector (in Million USD), 2025-2033
  • Table 5: Global: Bioinformatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Bioinformatics Market: Competitive Structure
  • Table 7: Global: Bioinformatics Market: Key Players